Further Study of AFGen1 Clinical Performance
Completed
- Conditions
- ECGAtrial FibrillationAfib
- Interventions
- Device: ECG co-measurementDevice: Periodic ECG triggered measurement
- First Posted Date
- 2024-03-28
- Last Posted Date
- 2024-06-20
- Lead Sponsor
- TriVirum, Inc.
- Target Recruit Count
- 20
- Registration Number
- NCT06335498
- Locations
- 🇺🇸
1808 49Th St Ct NW, Gig Harbor, Washington, United States
Clinical Performance of AFGen1
Completed
- Conditions
- Atrial FibrillationAfibECG
- Interventions
- Device: ECG co-measurement
- First Posted Date
- 2023-10-11
- Last Posted Date
- 2024-04-11
- Lead Sponsor
- TriVirum, Inc.
- Target Recruit Count
- 15
- Registration Number
- NCT06076798
- Locations
- 🇺🇸
4927 Lillian Street, San Diego, California, United States
Clinical Performance of the AFGen1 Device Over a 7-day Period
Completed
- Conditions
- AfibIrregular Heart BeatArrhythmias ParoxysmalArrhythmias, CardiacArrhythmia AtrialParoxysmal Atrial FibrillationAtrial Fibrillation
- Interventions
- Device: AFGen1 Device Wear TestDevice: AFGen 1 Device Single Use
- First Posted Date
- 2022-03-24
- Last Posted Date
- 2023-09-28
- Lead Sponsor
- TriVirum, Inc.
- Target Recruit Count
- 38
- Registration Number
- NCT05295056
- Locations
- 🇺🇸
Clayton Sleep Institute, Saint Louis, Missouri, United States
© Copyright 2025. All Rights Reserved by MedPath